X Leng1, L Lan1, L Liu2, T W Leung1, K S Wong1. 1. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. 2. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Abstract
BACKGROUND AND PURPOSE: Baseline collateral status has been correlated with outcomes of acute ischaemic stroke patients receiving intravenous thrombolysis (IVT) in previous studies. We carried out the current systematic review and meta-analysis to synthesize currently available evidence regarding such correlations. METHODS: Full-text articles published since 2000 were retrieved and screened. The overall effect sizes of good versus poor collateral status over a series of outcomes and certain baseline features were estimated by random-effects models and presented in risk ratios (RRs) or mean differences. RESULTS: Overall, 28 (3057 patients) and 14 (1584 patients) studies were included in qualitative and quantitative synthesis, respectively. Compared with poor pre-treatment collateral status, good collaterals showed a beneficial effect over the primary outcome of a favorable functional outcome at 3 or 6 months [RR, 2.45; 95% confidence interval, 1.94-3.09; P < 0.001] in acute ischaemic stroke patients receiving IVT treatment. However, such an effect tended to be different between studies with prescribed time windows of 3, 4.5 and > 4.5 h (up to 7 h), with the RRs being 2.21, 2.48 and 5.00, respectively (I2 = 53%). Good pre-treatment collaterals were also associated with a smaller infarct size at baseline, and a lower rate of symptomatic intracranial hemorrhage and a higher rate of neurological improvement early after IVT treatment. CONCLUSIONS: The present study has demonstrated the prognostic value of baseline collateral circulation for outcomes of acute ischaemic stroke patients receiving intravenous reperfusion therapies, studied with different time windows of up to 7 h after ictus for IVT therapy.
BACKGROUND AND PURPOSE: Baseline collateral status has been correlated with outcomes of acute ischaemic strokepatients receiving intravenous thrombolysis (IVT) in previous studies. We carried out the current systematic review and meta-analysis to synthesize currently available evidence regarding such correlations. METHODS: Full-text articles published since 2000 were retrieved and screened. The overall effect sizes of good versus poor collateral status over a series of outcomes and certain baseline features were estimated by random-effects models and presented in risk ratios (RRs) or mean differences. RESULTS: Overall, 28 (3057 patients) and 14 (1584 patients) studies were included in qualitative and quantitative synthesis, respectively. Compared with poor pre-treatment collateral status, good collaterals showed a beneficial effect over the primary outcome of a favorable functional outcome at 3 or 6 months [RR, 2.45; 95% confidence interval, 1.94-3.09; P < 0.001] in acute ischaemic strokepatients receiving IVT treatment. However, such an effect tended to be different between studies with prescribed time windows of 3, 4.5 and > 4.5 h (up to 7 h), with the RRs being 2.21, 2.48 and 5.00, respectively (I2 = 53%). Good pre-treatment collaterals were also associated with a smaller infarct size at baseline, and a lower rate of symptomatic intracranial hemorrhage and a higher rate of neurological improvement early after IVT treatment. CONCLUSIONS: The present study has demonstrated the prognostic value of baseline collateral circulation for outcomes of acute ischaemic strokepatients receiving intravenous reperfusion therapies, studied with different time windows of up to 7 h after ictus for IVT therapy.
Authors: Benjamin Okyere; William A Mills; Xia Wang; Michael Chen; Jiang Chen; Amanda Hazy; Yun Qian; John B Matson; Michelle H Theus Journal: J Clin Invest Date: 2020-02-03 Impact factor: 14.808
Authors: Elizabeth Holliday; Thomas Lillicrap; Timothy Kleinig; Philip M C Choi; Jane Maguire; Andrew Bivard; Lisa F Lincz; Monica Anne Hamilton-Bruce; Sushma R Rao; Marten F Snel; Paul J Trim; Longting Lin; Mark W Parsons; Bradford B Worrall; Simon Koblar; John Attia; Chris Levi Journal: BMJ Open Date: 2020-04-06 Impact factor: 2.692
Authors: Hyung Jin Lee; Hong Gee Roh; Sang Bong Lee; Yoo Sung Jeon; Jeong Jin Park; Taek-Jun Lee; Yu Jin Jung; Jin Woo Choi; Young Il Chun; Hee Jong Ki; Junsoo Cho; Ji Sung Lee; Hyun Jeong Kim Journal: Sci Rep Date: 2021-11-01 Impact factor: 4.379